Entero Healthcare Solutions (NSE:ENTERO) Ending Cash Position: ₹ Mil (As of Jun. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

NSE:ENTERO Entero Healthcare Solutions Ltd NSE:ENTERO
65 GF Score
Price ₹1,732.30
GF Value ₹1,617.72
Valuation Fairly Valued
! 6 Warning Signs
View Full Analysis

What is Entero Healthcare Solutions Ending Cash Position?

Entero Healthcare Solutions NSE:ENTERO +3.94% 65 Ending Cash Position is ₹ Mil as of Jun. 2026. GuruFocus rates NSE:ENTERO with a GF Score™ of 65/100 and a GF Value™ of ₹1,617.72 (Fairly Valued). The stock has 6 warning signs investors should review.

Entero Healthcare Solutions's Ending Cash Position for the quarter that ended in Jun. 2026 was ₹ Mil.

Entero Healthcare Solutions's quarterly Ending Cash Position increased from Dec. 2025 (₹ Mil) to Mar. 2026 (₹1,469 Mil) but then declined from Mar. 2026 (₹1,469 Mil) to Jun. 2026 (₹ Mil).

Entero Healthcare Solutions's annual Ending Cash Position increased from Mar. 2024 (₹1,476 Mil) to Mar. 2025 (₹2,293 Mil) but then declined from Mar. 2025 (₹2,293 Mil) to Mar. 2026 (₹1,469 Mil).

Entero Healthcare Solutions Ending Cash Position Related Terms

Entero Healthcare Solutions Ending Cash Position Historical Data

* Premium members only.

The historical data trend for Entero Healthcare Solutions's Ending Cash Position can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Entero Healthcare Solutions Ending Cash Position Chart

Entero Healthcare Solutions Annual Data
Trend Mar21 Mar22 Mar23 Mar24 Mar25 Mar26
Ending Cash Position
Get a 7-Day Free Trial 465.08 253.62 1,476.46 2,292.78 1,468.76

Entero Healthcare Solutions Quarterly Data
Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26 Jun26
Ending Cash Position Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only - 960.88 - 1,468.76 -
NSE:ENTERO
65GF Score
Entero Healthcare Solutions Ltd NSE:ENTERO
Ending Cash Position is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Entero Healthcare Solutions Ending Cash Position Calculation

Ending Cash Position is the cash and cash equivalents balance at the end of the accounting period, as indicated on the Cash Flow statement. It is equal to the Beginning Cash Position plus the Net Change in Cash.

Entero Healthcare Solutions's Ending Cash Position for the fiscal year that ended in Mar. 2026 is calculated as

Ending Cash Position= Beginning Cash Position+Net Change in Cash
=2300.73+-831.97
=1,469

Entero Healthcare Solutions's Ending Cash Position for the quarter that ended in Jun. 2026 is calculated as

Ending Cash Position=Beginning Cash Position+Net Change in Cash
=+
=0

Frequently Asked Questions Learn more about Ending Cash Position →
What does a Ending Cash Position of ₹ Mil mean?
Entero Healthcare Solutions (NSE:ENTERO) has a Ending Cash Position of ₹ Mil as of Jun. 2026. Ending Cash Position is the cash and cash equivalents balance at the end of the accounting period, as indicated on the Cash Flow statement. View historical data on Entero Healthcare Solutions and its competitors.
Is Entero Healthcare Solutions' Ending Cash Position too high?
Entero Healthcare Solutions' current Ending Cash Position is ₹ Mil. Overall, Entero Healthcare Solutions has a GF Score™ of 65/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does Entero Healthcare Solutions' Ending Cash Position compare to MCK and COR?
Entero Healthcare Solutions' Ending Cash Position of ₹ Mil can be compared against companies in the Medical Distribution industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Ending Cash Position for a Medical Distribution company?
A good Ending Cash Position depends on the Medical Distribution industry context. However, Ending Cash Position should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Ending Cash Position mean?
A high Ending Cash Position can signal that a stock is expensive relative to its fundamentals. Ending Cash Position is the cash and cash equivalents balance at the end of the accounting period, as indicated on the Cash Flow statement. View historical data on Entero Healthcare Solutions and its competitors. Entero Healthcare Solutions's current Ending Cash Position is ₹ Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Entero Healthcare Solutions stock overvalued right now?
Based on GuruFocus' analysis, Entero Healthcare Solutions (NSE:ENTERO) is currently considered Fairly Valued. The stock's GF Value™ is ₹1,617.72, compared to a current price of ₹1,732.30 — trading 7.1% above its estimated fair value. The current Ending Cash Position is ₹ Mil. Entero Healthcare Solutions' overall GF Score™ is 65/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Ending Cash Position calculated?
Ending Cash Position is calculated from a company's financial statements. For Entero Healthcare Solutions (NSE:ENTERO), the current Ending Cash Position is ₹ Mil as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Entero Healthcare Solutions (NSE:ENTERO) Overvalued in 2026?

Based on GuruFocus' analysis, Entero Healthcare Solutions stock appears to be overvalued. The current stock price of ₹1,732.30 is trading 7.1% above its estimated GF Value™ of ₹1,617.72. GuruFocus considers Entero Healthcare Solutions to be Fairly Valued.

Key valuation signals for NSE:ENTERO:

  • Ending Cash Position: ₹ Mil
  • GF Value™: ₹1,617.72 vs. price of ₹1,732.30 (7.1% above fair value)
  • GF Score™: 65/100 with 6 warning signs

No single metric tells the full story. See the NSE:ENTERO stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Entero Healthcare Solutions Business Description

Other Exchanges 544122:India
Address Bandra Kurla Complex, Trade Centre, Unit No. 605 & 606, 6th Floor, Bandra East, Mumbai, MH, IND, 400051
Entero Healthcare Solutions Ltd is a healthcare products distributor in India. It is involved in the business of distribution and marketing of pharmaceutical and surgical products and allied services. Geographically, the company derives a majority of its revenue from the domestic market.
65GF Score

Get the complete analysis for NSE:ENTERO

Ending Cash Position is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

₹1,732.30
Price
₹1,617.72
GF Value